Biotech · Private company
DualityBio Inc.
Track this companyFree. Adds DualityBio Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials1515 recruiting or active
Pipeline programs28From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline28
- CapecitabinePhase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- DB-1303/BNT323Phase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Nab-paclitaxelPhase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 3 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- AbirateronePhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BNT327Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BNT327Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- capecitabinePhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DB-1303/BNT323Phase 2 · HER2-positive Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DB-1305/BNT325Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DB-1305/BNT325Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DB-1310Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DB-1311Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DB-1311/BNT324Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- DB-1324Phase 2 · Gastrointestinal CancerClinicalTrials.gov · fetched Nov 12, 2026
- DB-1419Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- DB-2304Phase 2 · Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- itraconazolePhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ItraconazolePhase 2 · HER2-positive Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Lopinavir and Ritonavir TabletsPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- OsimertinibPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Pertuzumab InjectionPhase 2 · HER2-positive Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PrednisonePhase 2 · Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- RitonavirPhase 2 · HER2-positive Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DB-1317Phase 1 · Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerPHASE3 · RECRUITING · started Apr 22, 2026ClinicalTrials.gov NCT07365995 · fetched Nov 12, 2026
- A Study of DB-1324 in Advanced/Metastatic Gastrointestinal TumorsPHASE1_PHASE2 · RECRUITING · started Jan 20, 2026ClinicalTrials.gov NCT07263594 · fetched Nov 12, 2026
- A Study of DB-1317 in Selected Advanced/Metastatic Solid TumorsPHASE1 · RECRUITING · started Sep 23, 2025ClinicalTrials.gov NCT07141706 · fetched Nov 12, 2026
- DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsPHASE2 · RECRUITING · started Jul 18, 2025ClinicalTrials.gov NCT06953089 · fetched Nov 12, 2026
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerPHASE3 · RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT06340568 · fetched Nov 12, 2026
- AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)PHASE1_PHASE2 · RECRUITING · started Jun 4, 2025ClinicalTrials.gov NCT07038343 · fetched Nov 12, 2026
- A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerPHASE1_PHASE2 · RECRUITING · started May 2, 2025ClinicalTrials.gov NCT06892548 · fetched Nov 12, 2026
- A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerPHASE1_PHASE2 · RECRUITING · started Apr 23, 2025ClinicalTrials.gov NCT06827236 · fetched Nov 12, 2026
- A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE ParticipantsPHASE1_PHASE2 · RECRUITING · started Oct 4, 2024ClinicalTrials.gov NCT06625671 · fetched Nov 12, 2026
- First-in-human Study of DB-1419 for Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Sep 3, 2024ClinicalTrials.gov NCT06554795 · fetched Nov 12, 2026
- A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 18, 2024ClinicalTrials.gov NCT06018337 · fetched Nov 12, 2026
- A Study of DB-1310 in Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 17, 2023ClinicalTrials.gov NCT05785741 · fetched Nov 12, 2026
- A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 17, 2023ClinicalTrials.gov NCT05914116 · fetched Nov 12, 2026
- First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jul 19, 2022ClinicalTrials.gov NCT05438329 · fetched Nov 12, 2026
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Jan 31, 2022ClinicalTrials.gov NCT05150691 · fetched Nov 12, 2026